LONGMONT, Colo., Sept. 3, 2019 /PRNewswire/ -- Knowledge Center is empowering the State of Nebraska to contain costs, manage risks, and utilize a com

WAYNE, Pa., Sept. 3, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, announced that Bob Radie, president and chief executive officer of Zyla, will give a corporate presentation and participate in a panel at the 2019 Disruptive Growth Conference. The presentation will be at

SEATTLE, Sept. 3, 2019 /PRNewswire/ -- When ExorVision was founded, they worked directly with dentists to produce a custom-built monitor that addressed the high safety and quality standards re

VIRGINIA BEACH, Va., Sept. 3, 2019 /PRNewswire/ -- Optima Health announced that it is providing the Healthy Savings program to its Medicaid members. This unique program provides greater access to fresh produce and other healthier food items, as well as over-the-counter medications, baby care and household cleaning items."As a health plan that invests in our m

HOUSTON, Sept. 3, 2019 /PRNewswire/ -- The Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children's Hospital and Leica Microsystems, Inc. combined efforts to establish the Leica Microsystems Center of Excellence at the NRI. The new Center will support a mission to drive new discoveries and insights from scientific research performed using the ima

SEATTLE, Sept. 3, 2019 /PRNewswire/ -- Fred Hutchinson Cancer Research Center (Fred Hutch) and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at Fred Hutch. The new Center will support a mission to drive new discoveries and insights from scientific research performed using the imaging systems.

KING OF PRUSSIA, Pa., Sept. 3, 2019 /PRNewswire/ -- With a raging opioid epidemic in the U.S. and millions of leftover prescripti

LAS VEGAS, Sept. 3, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making any decisions on the pending applications, the DEA intends to distribute regulations that govern the program of growing marijuana for scientific research under DEA registration.&nb

SAN JOSE, Calif., Sept. 3, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today announced results from the Company's first-in-patient Phase 2 clinical trial evaluating AR-105, a fully human I

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- The presence of chemicals made as the body breaks down fats, proteins, and carbohydrates can predict whether Sept. 11, 2001 first responders exposed to toxic dust at the World Trade Center site subsequently develop lung disease, a new study finds.